Trial intelligence / Profile preview

Acetohydroxamic Acid for Urea Recycling in UCD

NCT03181828Phase 2Terminated

Start
Mar 2017
Primary completion
Jun 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of acetohydroxamic acid in urea cycle disorders (UCD). Started Mar 2017; status: terminated.

02

Drugs

acetohydroxamic acid
03

Conditions

urea cycle disorders (UCD)

Beyond the preview

Go deeper on NCT03181828.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03181828.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call